Ocular Therapeutix, Inc. (OCUL)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 325
- Market Cap
- $1.9B
About Ocular Therapeutix, Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
SentiSense also tracks daily options readings for Ocular Therapeutix, Inc.: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Ocular Therapeutix, Inc. stock analysis, sentiment tracking, and market intelligence on SentiSense.